Market revenue in 2022 | USD 975.2 million |
Market revenue in 2030 | USD 769.2 million |
Growth rate | -2.9% (CAGR from 2022 to 2030) |
Largest segment | Nasopharyngeal (np) swab |
Fastest growing segment | Oropharyngeal (OP) swab |
Historical data | 2020 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nasopharyngeal (NP) swab, Oropharyngeal (OP) swab, Nasal Swabs, Saliva |
Key market players worldwide | Abbott Laboratories, Mylab Discovery Solutions, Converge Technology Solutions Corp, Thermo Fisher Scientific Inc, Roche, Danaher Corp, Birks Group Inc Class A, Cue Health Inc, Quest Diagnostics Inc, SD Biosensor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 detection poc kits market will help companies and investors design strategic landscapes.
Nasopharyngeal (np) swab was the largest segment with a revenue share of 57.54% in 2022. Horizon Databook has segmented the U.S. covid-19 detection poc kits market based on nasopharyngeal (np) swab, oropharyngeal (op) swab, nasal swabs, saliva covering the revenue growth of each sub-segment from 2020 to 2030.
The U.S. dominated the market in North America with more than 94.8% of the revenue share in 2021. Increase in COVID-19 cases, coupled with continuous expedited approvals for diagnostic tests manufactured by key players, is the major factor driving this market.
According to WHO, from January 2020 to September 2022, 94,965,623 cases were confirmed in the country, with 1,047,392 related deaths. The local presence of key laboratories, such as Quest Diagnostics and Laboratory Corporation of America (LabCorp), strengthened the country's COVID-19 diagnostics market.
As of June 2021, Quest Diagnostics conducted around 41.8 million COVID-19 molecular diagnostic tests and nearly 6.2 million COVID-19 antibody tests. In March 2021, the U.S. government initiated serial testing for COVID-19.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. covid-19 detection poc kits market , including forecasts for subscribers. This country databook contains high-level insights into U.S. covid-19 detection poc kits market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account